Selvita S.A. (WAR:SLV) — Market Cap & Net Worth
Market Cap & Net Worth: Selvita S.A. (SLV)
Selvita S.A. (WAR:SLV) has a market capitalization of $131.82 Million (zł478.98 Million) as of September 16, 2026. Listed on the WAR stock exchange, this Poland-based company holds position #18225 globally and #127 in its home market, demonstrating a -2.25% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Selvita S.A.'s stock price zł26.10 by its total outstanding shares 18351725 (18.35 Million). Also see Selvita S.A. (SLV) total assets for a full breakdown of the balance sheet.
Selvita S.A. Market Cap History: 2019 to 2026
Selvita S.A.'s market capitalization history from 2019 to 2026. Data shows growth from $118.69 Million to $131.82 Million (3.19% CAGR). Also see SLV operating cash flow for how efficiently the company converts equity into cash flow.
Index Memberships
Selvita S.A. is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
mWIG40
MWIG40
|
$73.62 Billion | 0.18% | #36 of 40 |
Weight: Selvita S.A.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Selvita S.A. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Selvita S.A.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check SLV stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.60x
Selvita S.A.'s market cap is 0.60 times its annual revenue
Latest Price to Earnings (P/E) Ratio
268.37x
Selvita S.A.'s market cap is 268.37 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $118.69 Million | $30.44 Million | $5.52 Million | 3.90x | 21.49x |
| 2020 | $249.00 Million | $137.36 Million | $18.00 Million | 1.81x | 13.83x |
| 2021 | $414.15 Million | $310.92 Million | $14.90 Million | 1.33x | 27.80x |
| 2022 | $418.70 Million | $360.68 Million | $30.31 Million | 1.16x | 13.81x |
| 2023 | $295.46 Million | $346.72 Million | $69.88 Million | 0.85x | 4.23x |
| 2024 | $250.01 Million | $342.01 Million | -$6.10 Million | 0.73x | N/A |
| 2025 | $218.19 Million | $364.47 Million | $813.00K | 0.60x | 268.37x |
Competitor Companies of SLV by Market Capitalization
Companies near Selvita S.A. in the global market cap rankings as of September 16, 2026. Review how tangible is Selvita S.A.'s equity to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Selvita S.A. by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #88 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #161 globally with a market cap of $147.88 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #476 globally with a market cap of $56.70 Billion USD ( CN¥387.49 Billion CNY).
- Natera Inc (NASDAQ:NTRA): Ranked #578 globally with a market cap of $47.01 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #88 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $641.39 |
| #161 | Danaher Corporation | NYSE:DHR | $147.88 Billion | $209.36 |
| #476 | WuXi AppTec Co Ltd | SHG:603259 | $56.70 Billion | CN¥156.67 |
| #578 | Natera Inc | NASDAQ:NTRA | $47.01 Billion | $350.78 |
Selvita S.A. Historical Marketcap From 2019 to 2026
Between 2019 and today, Selvita S.A.'s market cap moved from $118.69 Million to $ 131.82 Million, with a yearly change of 3.19%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | zł131.82 Million | -39.58% |
| 2025 | zł218.19 Million | -12.73% |
| 2024 | zł250.01 Million | -15.38% |
| 2023 | zł295.46 Million | -29.43% |
| 2022 | zł418.70 Million | +1.10% |
| 2021 | zł414.15 Million | +66.33% |
| 2020 | zł249.00 Million | +109.79% |
| 2019 | zł118.69 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Selvita S.A. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $131.82 Million USD |
| MoneyControl | $131.82 Million USD |
| MarketWatch | $131.82 Million USD |
| marketcap.company | $131.82 Million USD |
| Reuters | $131.82 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Selvita S.A.
Selvita S.A. provides drug discovery, drug development, and contract testing services in Poland. The company offers computer-aided drug design and artificial intelligence solutions, including structure-based drug design, virtual screening, and bioinformatics; medicinal and synthetic, analytical, and solid state chemistry, as well as process chemistry and scale up, and compound management and libr… Read more